If you or a loved one has been diagnosed with cancer after using prescription or over the counter Zantac (ranitidine), we urge you to contact our pharmaceutical liability attorneys by filling out the form below or calling 1.800.556.5522. The FDA has recently withdrawn these medications from the market and you may be entitled to pursue legal action.

Zantac
First
Last
Address *
Address
Street
City
State/Province
Zip/Postal
Country
Have you or a family member taken Zantac or ranitidine?

At this time, we are only reviewing cases of those who were prescribed this medication. Thank you for your inquiry

Please provide us additional information about your Zantac or ranitidine use

Have you or a family member been diagnosed with: *

At this time, we are only reviewing cases of those who were prescribed this medication or developed one of the cancers listed above . Thank you for your inquiry

Did you or a family member take Zantac or ranitidine for at least one year prior to a cancer diagnosis? *
Which of the following accurately describes your use of Zantac? (select all that apply)

What is Zantac?

Zantac is an antacid and antihistamine primarily used to treat and prevent heartburn, but can also be used to treat stomach ulcers, gastroesophageal reflux disease (GERD) and other gastrointestinal disorders. The drug is known as ranitidine in its generic form.

Drug safety officials in the U.S. and Europe have launched an investigation into whether Sanofi heartburn medication, Zantac, and other generic versions made by numerous manufacturers contain levels of the probable carcinogen N-nitrosodimethylamine (NDMA) that could pose a danger to patients

What is NDMA?

NDMA is common industrial byproduct and is a contaminant found in small quantities in meat, vegetables, dairy and water. It is classified as a probable human carcinogen, meaning that it is a substance that could cause cancer when consumed in certain quantities.

Contact the Pharmaceutical Liability Attorneys at The Law Offices of Peter Angelos Today. 

The recent discovery of traces of NDMA in popular drug Zantac and other generic versions of the drug is alarming and demonstrates the necessity of mass-manufactured pharmaceutical drug companies to ensure proper steps are being taken to uphold public health. The pharmaceutical liability attorneys at The Law Offices of Peter Angelos urge you to fill out the form below if you or a loved one has taken Zantac or ranitidine that contains NDMAs.

What Companies are Involved in Litigation?

The discovery of traces of NDMA found in generic Zantac led major drug manufacturers to recall their products. Specific lots of the popular over-the-counter medication have been voluntarily pulled from shelves by numerous manufacturing and distribution companies all over the world, including Sandoz Inc., GlaxoSmithKline—the original manufacturer of branded Zantac—and Dr. Reddy’s. The recent contamination concerns led Sandoz Inc. to halt the distribution of its product indefinitely until further decisions are made regarding the safety of the product. Sandoz Inc. will voluntarily recall all quantities and lots of Ranitidine Hydrochloride (Zantac) that have expiration dates between April 30, 2020 and March 31, 2021, as those lots have been confirmed to be contaminated with NDMA.